Protecting bone in long-term HIV positive patients receiving antiretrovirals.

about

Cost-effective osteoporosis treatment thresholds for people living with HIV infection in Greece.International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

P2860

Q49334645-E4B788B6-BEC8-4D44-A44D-E3BD914751E4 Q56762706-24235489-72F2-45EA-9382-3C7127A35950

P2860

Protecting bone in long-term HIV positive patients receiving antiretrovirals.

Item

http://www.wikidata.org/entity/Q38836871

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Protecting bone in long-term HIV positive patients receiving antiretrovirals.

@en

type

Item

label

Protecting bone in long-term HIV positive patients receiving antiretrovirals.

@en

prefLabel

Protecting bone in long-term HIV positive patients receiving antiretrovirals.

@en

P1476

Protecting bone in long-term HIV positive patients receiving antiretrovirals.

@en

P2093

Patrick Mallon

http://www.w3.org/2001/XMLSchema#string

Tara McGinty

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

Bone resorption by osteoclasts

A cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 study

Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

P304

587-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/14787210.2016.1184570

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27189695

http://www.w3.org/2001/XMLSchema#string

Protecting bone in long-term HIV positive patients receiving antiretrovirals.

about

P2860

P2860

Protecting bone in long-term HIV positive patients receiving antiretrovirals.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698